Market Overview
The Spatial Genomics and Transcriptomics
market is predicted to develop at a compound annual growth rate (CAGR) of 10.92%
from 2024 to 2033, when it is projected to reach USD 510.2 million, based on an
average growth pattern. The market is estimated to reach a value of USD 254.3 million
in 2024.
SOURCE: We Market Research
New tools such
as transcriptomics and spatial genomics allow researchers to study the spatial
organization of genes and their expression in various tissues and organs.
Unlike standard genomics and transcriptomics techniques that provide bulk
measurements, spatial approaches highlight the intricate spatial relationships
among genes, cells, and tissues. These methodologies leverage state-of-the-art
imaging and sequencing capabilities to map the spatial distribution of
transcripts and genetic features within the context of complex biological
structures. By interpreting the spatial organization of genetic information,
spatial genomics and transcriptomics are revolutionizing biology and medicine
by offering hitherto unreachable insights into disease processes, tissue
architecture, and cellular function.
There are
Several major drivers are driving the market for transcriptomics and spatial
genomics, the need for high-resolution spatial analysis tools in drug
development and biological research is growing, which drives market expansion.
Second, the development of bioinformatics tools and sequencing technologies has
made it possible to profile genes and transcripts more thoroughly and
efficiently in space. Furthermore, the need for spatially resolved molecular
insights is increased by the increasing prevalence of complex diseases such as
neurological disorders and cancer. Furthermore, partnerships between research
centers, drug manufacturers, and IT firms encourage new product creation and
innovation, which drives market growth even more. The market for spatial
genomics and transcriptomics is expanding quickly due to these factors
together, and they provide revolutionary options for precision medicine and
biomedical research.
Market Scope
Report Attributes |
Description |
Market Size in 2024 |
USD 254.3 Million |
Market Forecast in 2033 |
USD 510.2 Million |
CAGR % 2024-2033 |
10.92% |
Base Year |
2023 |
Historic Data |
2016-2022 |
Forecast Period |
2024-2033 |
Report USP
|
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
Segments Covered |
By Technology, by Workflow, by Product Type, by Application, by
End User and By Region |
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia;
Thailand; Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa;
Nigeria |
Spatial Genomics and Transcriptomics Industry:
Dynamics & Restrains
Market Drivers
Growing
Applications in Drug Discovery and Development - The market for spatial genomics and transcriptomics is being driven
primarily by expanding applications in drug discovery and development. These
technologies provide accurate information about the interactions between
molecules and cells within tissues, which helps identify new drug targets,
comprehend pharmacological processes, and assess the safety and effectiveness
of drugs. Spatial genomics and transcriptomics help to provide targeted
therapeutics customized for specific patients by allowing researchers to
investigate gene expression and spatial organization at the single-cell level.
The growing need for spatial analysis technologies as a result of its crucial
function in the advancement of precision medicine propels market expansion and
innovation in medication research and development procedures.
Increasing
Research Funding and Investments - A major
factor propelling the market for spatial genomics and transcriptomics is rising
research expenditures and funding. Developments in technology, product
creation, and commercialization are accelerated in the sector by the inflow of
funding from governments, universities, and private investors. Through this
financing, researchers can carry out longer-term investigations, create
cutting-edge tools for spatial analysis, and investigate novel applications in
fields including precision medicine, medication development, and disease
research. Furthermore, financial investments encourage academic and business
alliances and collaborations, which facilitate the transfer of technology and
information. Funding and investment increases ultimately drive market expansion
by promoting innovation and broadening the use of transcriptomics and spatial
genomics technologies.
Market restrains
Limited
Understanding of Spatial Biology - The market
for spatial genomics and transcriptomics is significantly restricted by the
limited understanding of spatial biology. The present comprehension of the
complex spatial linkages and interactions found within tissues is still
restricted, despite technological breakthroughs. Due to the increased
difficulty in interpreting geographic transcriptome and genomic data, this
restricts the amount of physiologically significant information that could be
discovered and the range of possible applications. Scholars lacking expertise
in spatial biology may encounter challenges when assessing data in fields like
disease investigation, pharmaceutical development, and precision medicine,
thereby impeding advancements. To fully realize the promise of spatial analytic
technologies and spur business expansion, bridging this knowledge gap will
necessitate further research and cooperation.
We Market
Research: Spatial Genomics and
Transcriptomics Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Spatial Genomics and Transcriptomics Segmentation
Market- By Technology Analysis
By Technology, the Spatial Genomics and Transcriptomics Market is Categories into Spatial Transcriptomics, Spatial Genomics. The Spatial Transcriptomics segment accounts for the largest share of around 54% in 2024.
Gene expression data that is geographically
resolved and of high resolution is provided by spatial transcriptomics, which
can be used to understand disease mechanisms and cellular connections. Growing
within the global spatial genomics and transcriptomics market, its uses in
neuroscience and oncology are propel the market growth.
The
following segments are part of an in-depth analysis of the global Spatial Genomics
and Transcriptomics market:
Market Segments |
|
By Workflow |
·
Spatial Imaging ·
Spatial Analysis ·
Spatial Sequencing |
By Product Type |
·
Instruments ·
Consumables ·
Software |
By Application |
·
Translational Research ·
Drug Discovery &
Development |
By End User |
·
Pharmaceutical Manufacturer ·
Diagnostic Customers ·
Academic & Research
Institutes |
Spatial Genomics and Transcriptomics Industry: Regional Analysis
North America Market Forecast
North America dominate the Spatial Genomics and Transcriptomics Market with the highest revenue generating market with share of more than 47%. North America's well-established research infrastructure, significant R&D spending by the public and private sectors, and the concentration of biotechnology and pharmaceutical companies, which promote innovation and propel market growth, all contribute to the region's success in the spatial genomics and transcriptomics market.
Europe Market Statistics
Europe is the
second-largest market for Spatial Genomics and Transcriptomics. A favorable
ecosystem for the development and uptake of spatial genomics and
transcriptomics technologies has been created in Europe by the market's
favorable regulatory framework, significant governmental and private funding
for life sciences research, and growing utilisation of precision medicine
techniques.
Asia Pacific Market Forecasts
Asia Pacific is expected
to be the fastest-growing market for Spatial Genomics and Transcriptomics
during the forecast period. Factors including escalating healthcare expenses,
the biotechnology industry's rapid expansion, and the growing collaborations
between domestic and international research institutes are driving the spatial
genomics and transcriptomics market in the Asia-Pacific region. Innovation and
the broad use of spatial analytic technology for many applications are being
promoted by these collaborations.
Key Market Players
The Spatial
Genomics and Transcriptomics Market is dominated by a few large companies, such
as
·
10XGenomics (US)
·
Illumina (US)
·
Bio-Rad Laboratories (US)
·
Bio-Techne Corporation (US)
·
Standard BioTools Inc. (US)
·
Genomic Vision SA (France)
·
Akoya Biosciences, Inc. (US)
·
Danaher Corporation (US)
·
Natera, Inc.(US)
·
PerkinElmer, Inc. (US)
·
Seven Bridges Genomics (US)
·
S2 Genomics, Inc. (US)
·
Cantata Bio (US)
·
Others
Recent Developments:
·
2022, Abcam and NanoString
established a partnership to co-market Abcam antibodies for the high-plex
spatial multiomics products offered by NanoString.
·
2022, AstraZeneca and Illumina
have established a strategic research partnership aimed at accelerating the
discovery of new therapeutic targets by fusing industry knowledge with AI-based
genome interpretation and genomic analysis capabilities.
1.
Global
Spatial Genomics and Transcriptomics Market Introduction and Market Overview
1.1. Objectives of the Study
1.2. Global Spatial Genomics and
Transcriptomics Market Scope and Market Estimation
1.2.1. Global Spatial Genomics and
Transcriptomics Overall Market Size, Revenue (US$ Mn), Market CAGR (%), Market
forecast (2023 - 2033)
1.2.2. Global Spatial Genomics and
Transcriptomics Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2033
1.3. Market Segmentation
1.3.1. Component of Global Spatial
Genomics and Transcriptomics Market
1.3.2. Technology of Global Spatial
Genomics and Transcriptomics Market
1.3.3. Product Type of Global Spatial
Genomics and Transcriptomics Market
1.3.4. Region of Global Spatial
Genomics and Transcriptomics Market
2.
Executive Summary
2.1. Global Spatial Genomics and Transcriptomics Market Industry Trends under
COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Spatial Genomics and
Transcriptomics Market Industry Development
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3. Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4. Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5. Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6. Value Chain / Ecosystem Analysis
2.7. Russia-Ukraine War Impacts
Analysis
2.8. Economic Downturn Analysis
2.9. Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3. Global Spatial Genomics and Transcriptomics Market Estimates & Historical Trend Analysis (2019 - 2022)
4. Global Spatial
Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by
TECHNOLOGY
4.1. Global Spatial Genomics and
Transcriptomics Market Revenue (US$ Mn) Estimates and Forecasts, by TECHNOLOGY,
2019 to 2033
4.1.1. Spatial Transcriptomics
4.1.2. Spatial Genomics
5. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by Workflow
5.1. Global Spatial Genomics and Transcriptomics
Market Revenue (US$ Mn) Estimates and Forecasts, by Workflow, 2019 to 2033
5.1.1. Spatial Imaging
5.1.2. Spatial Analysis
5.1.3. Spatial Sequencing
6. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by Product Type
6.1. Global Spatial Genomics and Transcriptomics Market Revenue (US$ Mn) Estimates and Forecasts, by Product Type, 2019 to 2033
6.1.1. Instruments
6.1.2. Consumables
6.1.3. Software
7. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by APPLICATION
7.1. Global Spatial Genomics and Transcriptomics Market Revenue (US$ Mn) Estimates and Forecasts, by Product Type, 2019 to 2033
7.1.1. Translational Research
7.1.2. Drug Discovery & Development
8. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by END USER
8.1. Global Spatial Genomics and Transcriptomics Market Revenue (US$ Mn) Estimates and Forecasts, by Product Type, 2019 to 2033
8.1.1. Pharmaceutical Manufacturer
8.1.2. Diagnostic Customers
8.1.3. Academic & Research
Institutes
9. Global Spatial Genomics and Transcriptomics Market Estimates & Forecast Trend Analysis, by Region
9.1. Global Spatial Genomics and
Transcriptomics Market Revenue (US$ Mn) Estimates and Forecasts, by Region,
2019 to 2033
9.1.1. North America
9.1.2. Europe
9.1.3. Asia Pacific
9.1.4. Middle East & Africa
9.1.5. South America
10. North America Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis
10.1. North
America Spatial Genomics and Transcriptomics Market Assessments & Key
Findings
10.1.1. North America Spatial Genomics
and Transcriptomics Market Introduction
10.1.2. North America Spatial Genomics
and Transcriptomics Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
10.1.2.1. By TECHNOLOGY
10.1.2.2. By Workflow
10.1.2.3. By Product Type
10.1.2.4. By APPLICATION
10.1.2.5. By END USER
10.1.2.6. By Country
10.1.2.6.1. The U.S.
10.1.2.6.2. Canada
10.1.2.6.3. Mexico
11. Europe Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis
11.1. Europe Spatial Genomics and
Transcriptomics Market Assessments & Key Findings
11.1.1. Europe Spatial Genomics and
Transcriptomics Market Introduction
11.1.2. Europe Spatial Genomics and Transcriptomics
Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
11.1.2.1. By TECHNOLOGY
11.1.2.2. By Workflow
11.1.2.3. By Product Type
11.1.2.4. By APPLICATION
11.1.2.5. By END USER
11.1.2.6. By Country
11.1.2.6.1. Germany
11.1.2.6.2. U.K.
11.1.2.6.3. France
11.1.2.6.4. Italy
11.1.2.6.5. Spain
11.1.2.6.6. Russia
11.1.2.6.7. Rest of Europe
12. Asia Pacific Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis
12.1. Asia Pacific Market Assessments
& Key Findings
12.1.1. Asia Pacific Spatial Genomics
and Transcriptomics Market Introduction
12.1.2. Asia Pacific Spatial Genomics
and Transcriptomics Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
12.1.2.1. By TECHNOLOGY
12.1.2.2. By Workflow
12.1.2.3. By Product Type
12.1.2.4. By APPLICATION
12.1.2.5. By END USER
12.1.2.6. By Country
12.1.2.6.1. China
12.1.2.6.2. Japan
12.1.2.6.3. India
12.1.2.6.4. Australia
12.1.2.6.5. South Korea
12.1.2.6.6. ASEAN
12.1.2.6.7. Rest of Asia Pacific
13. Middle East & Africa Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis
13.1. Middle East & Africa Market
Assessments & Key Findings
13.1.1. Middle
East & Africa Spatial
Genomics and Transcriptomics Market Introduction
13.1.2. Middle East & Africa Spatial Genomics and Transcriptomics Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
13.1.2.1. By TECHNOLOGY
13.1.2.2. By Workflow
13.1.2.3. By Product Type
13.1.2.4. By APPLICATION
13.1.2.5. By END USER
13.1.2.6. By Country
13.1.2.6.1. U.A.E.
13.1.2.6.2. Saudi Arabia
13.1.2.6.3. Egypt
13.1.2.6.4. South Africa
13.1.2.6.5. Rest of Middle East & Africa
14. South America Spatial Genomics and Transcriptomics Market: Estimates & Forecast Trend Analysis
14.1. South America Market Assessments
& Key Findings
14.1.1. South America Spatial Genomics
and Transcriptomics Market Introduction
14.1.2. South America Spatial Genomics
and Transcriptomics Market Size Estimates and Forecast (US$ Million) (2019 – 2033)
14.1.2.1. By TECHNOLOGY
14.1.2.2. By Workflow
14.1.2.3. By Product Type
14.1.2.4. By APPLICATION
14.1.2.5. By END USER
14.1.2.6. By Country
14.1.2.6.1. Brazil
14.1.2.6.2. Argentina
14.1.2.6.3. Colombia
14.1.2.6.4. Rest of South America
15. Competition Landscape
15.1. Global Spatial Genomics and
Transcriptomics Market Competition Matrix & Benchmarking, by Leading
Players / Innovators / Emerging Players / New Entrants
15.2. Global Spatial Genomics and
Transcriptomics Market Competition White Space Analysis, By Product Type
15.3. Global Spatial Genomics and
Transcriptomics Market Competition Heat Map Analysis, By Product Type
15.4. Global Spatial Genomics and
Transcriptomics Market Concentration & Company Market Shares (%) Analysis,
2022
16. Company Profiles
16.1. 10XGenomics (US)
16.1.1. Company Overview & Key Stats
16.1.2. Financial Performance & KPIs
16.1.3. Product Portfolio
16.1.4. Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned below
16.2. Illumina (US)
16.3. Bio-Rad
Laboratories (US)
16.4. Bio-Techne
Corporation (US)
16.5. Standard
BioTools Inc. (US)
16.6. Genomic Vision
SA (France)
16.7. Akoya
Biosciences, Inc. (US)
16.8. Danaher
Corporation (US)
16.9. Natera,
Inc.(US)
16.10. PerkinElmer,
Inc. (US)
16.11. Seven Bridges
Genomics (US)
16.12. S2 Genomics,
Inc. (US)
16.13. Cantata Bio
(US)
16.14. Others
17. Research
Methodology
17.1. External Transportations /
Databases
17.2. Internal Proprietary Database
17.3. Primary Research
17.4. Secondary Research
17.5. Assumptions
17.6. Limitations
17.7. Report FAQs
18. Research Findings & Conclusion
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Spatial Genomics and Transcriptomics Market was valued at USD 254.3 Million in 2024.
Spatial Genomics and Transcriptomics Market size will increase at approximate CAGR of 10.92% during the forecasted period.
Major companies operating within the Spatial Genomics and Transcriptomics Market are 10XGenomics (US), Illumina (US), Bio-Rad Laboratories (US), Bio-Techne Corporation (US), Standard BioTools Inc. (US), Genomic Vision SA (France), Akoya Biosciences, Inc. (US), Danaher Corporation (US), Natera, Inc.(US), PerkinElmer, Inc. (US), Seven Bridges Genomics (US), S2 Genomics, Inc. (US), Cantata Bio (US) and Other.
North America dominates the market with an active share of 47%.
Only Three Thousand Four Hundred Ninety Nine US dollar
Only Four Thousand Four Hundred Ninety Nine US dollar
Only Five Thousand Four Hundred Ninety Nine US dollar